The Avita Medical share price just leapt 17%! What's going on?

Avita Medical shares are now up a whopping 110% in 2023.

| More on:
A group of science or medical professionals cheering good news in the lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Inc (ASX: AVH) share price is having a banner day.

Shares in the ASX healthcare stock closed yesterday trading for $3.56. In morning trade on Tuesday, shares were swapping hands for $4.16, up a whopping 16.9%.

After what looks to be a bit of profit-taking, shares are currently trading for $4.06 apiece, up 14.04%.

With those gains factored in, the Avita Medical share price is up a stellar 110% in 2023.

For some context, the All Ordinaries Index (ASX: XAO) is up 0.64% today and up 1% year to date.

So, what's stirring investor interest in the regenerative medicine company today?

What's lifting the Avita Medical share price?

With no fresh price-sensitive news out from the ASX healthcare share, the Avita Medical share price looks to be rebounding from its 4% sell-down yesterday and continuing in line with Friday's 16.7% gains.

Friday's gains were spurred by the company's third-quarter update, with investors reacting positively to Avita's commercial revenue growth.

Commercial revenue increased 51% over the three months to reach US$13.5 million.

And investors weren't put off by the 48% increase in operating expenses, which saw Avita's net loss increase 55% to US$8.7 million over the quarter.

Investors may have shrugged off that loss because the company retained just over US$60 million cash on hand, which management said was enough to meet its profitability goals.

Crucially, Avita Medical CEO Jim Corbett anticipates the company will receive US FDA approval for its Recell Go product by mid-2024.

"We expect to submit a response to the FDA's open questions on February 28, 2024," Corbett said.

"Under the Breakthrough Device program, we anticipate FDA approval on May 30, 2024, which positions us for a launch the following day," he added.

That long-awaited FDA approval, should it come through, could offer some sustained tailwinds for the Avita Medical share price.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Boss Energy, Core Lithium, Latin Resources, and Santos shares are rising today

These ASX shares are having a good finish to the week. But why?

Read more »

Happy woman in purple clothes looking at asx share price on mobile phone
Share Gainers

Why Invictus Energy, Perpetual, Polynovo, and Zip shares are charging higher

These ASX shares are catching the eye on Thursday. What's going on?

Read more »

two men in mining hats shake hands on a deal with gas pipelines in the background, indicating a deal between Senex and 29 Metals
Share Gainers

Guess which ASX All Ords share just leapt 59% on a new gas discovery

Investors are bidding up the ASX All Ords energy share following a significant gas discovery in southern Africa.

Read more »

Businesswoman whispering in male colleague's ear as he looks surprised
Share Gainers

Up 118%: Is this 'high quality' stock the best-kept secret on the ASX 200?

Why are these pharmaceutical shares turning heads at the moment? The Elvest team explains.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Chalice Mining, Core Lithium, Perpetual, and Polynovo shares are racing higher

These ASX shares are having a very strong session on Wednesday. But why?

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

'Double-digit earnings growth': 2 fast-rising ASX shares not too late to buy

Get on these stocks before all their potential is realised, say Celeste analysts. So what are you waiting for?!

Read more »

Top 10 blank list on chalkboard
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to reality for ASX shares today...

Read more »

Beautiful young couple enjoying in shopping, symbolising passive income.
Share Gainers

Why Droneshield, Origin, ResMed, and Whispir shares are pushing higher

These ASX shares are having a good time despite the market weakness.

Read more »